Profitelligence Profitelligence · Filing Ledger Open SYK research →

Form 8-K · Current Report · Filed 2025-05-13

Stryker Corporation Shareholder Approval of Incentive Plans and Annual Meeting Voting Results

On May 8, 2025, Stryker Corporation's shareholders approved an increase in the number of shares available for issuance under the 2011 Long-Term Incentive Plan, the 2011 Performance Incentive Award Plan, and the 2008 Employee Stock Purchase Plan.

Filer
Stryker Corporation SYK · NYSE
Filed
Accession
0000310764-25-000085
CIK
0000310764
Signal
High impactHealthcare

Details

The shareholders also elected all ten directors to serve until the next Annual Meeting and ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025. An advisory vote on the compensation of named executive officers was also approved.

Items reported

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

New CEO Appointed CFO Resignation
Item 5.07

Submission of Matters to a Vote of Security Holders

Director Elections Results Equity Plan Approved

Market reaction

Close before filing

$388.08

Next session

-0.5%

Since filing

-16.1%

Latest close

$325.70

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from SYK reporting the same item, with the next session's move:

About Stryker Corporation

Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.

Exchange NYSE Industry Medical Devices Company website ↗

Never miss another SYK filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts